Oriflame has announced new scientific findings around Oripeptide-3, its patented bioactivating technology and the cornerstone of the NovAge+ skincare range. The announcement is joined with Oriflame marking three decades of operations in India. Read along to know more about these developments.
The new scientific evidence data by Oriflame reveals that Oripeptide-3 directly supports five key biological drivers of skin ageing, marking an important milestone in the brand’s long-term research into skin longevity, cellular health and the science of ageing well.
The findings reinforce Oriflame’s focus on moving beyond surface-level skincare solutions towards interventions that work at a molecular and cellular level to support long-term skin health and performance.
Nearly two decades of development
Developed over almost twenty years, Oripeptide-3 has been designed to work in synergy with the skin’s natural biology. The technology aims to help extend the skin’s functional lifespan by strengthening core longevity markers associated with resilience, repair and overall skin vitality.
According to the latest research, Oripeptide-3 plays a role in improving overall skin function while supporting healthier-looking, more youthful skin over time. This positions the ingredient as a central innovation within Oriflame’s NovAge+ range, which is built around the concept of proactive and preventative skin ageing.
Targeting the five hallmarks of skin ageing
Oripeptide-3 works across five recognised hallmarks of ageing. It supports the reactivation of aged skin cells, helping improve overall skin function. The technology also helps protect DNA integrity, which contributes to better firmness and elasticity.
In addition, Oripeptide-3 helps maintain protein quality within the skin, reducing oxidative stress and enhancing radiance. It supports natural cellular renewal processes, improving clarity and vitality, while also boosting cellular energy levels required for repair, renewal and daily defence. Together, these actions address multiple ageing pathways rather than focusing on a single visible concern.
Expert perspectives on longevity-led beauty
“Longevity is rightly the next frontier in beauty and we are proud to be leading this transformation with our skin longevity research at the molecular and cellular level,” said Lene Visdal-Johnsen, PhD, Director, Scientific Research and Innovation, Oriflame Global R&D.
Highlighting the consumer relevance of this approach, Edyta Kurek, Senior Vice President & Head, Oriflame India and Indonesia, added, “As consumers increasingly look for solutions that work deeper and deliver long-term skin benefits, innovations like Oripeptide-3 reflect our focus on advanced research and future-ready skincare.”
Three decades of Oriflame in India
The announcement comes around the time when Oriflame marks thirty years of its presence in India. Entering the market in the early 1990s, the Swedish beauty and well-being brand has built a strong footprint through science-backed innovation, consistent product quality and a long-standing commitment to entrepreneurship.
Rooted in its Swedish heritage, Oriflame today offers a portfolio of over 500 products across skincare, wellness, colour cosmetics, haircare, personal care and fragrance. Iconic products such as Tender Care balm and Milk and Honey Body Creams continue to be key pillars of the brand. Tender Care, now also manufactured in India, remains a bestseller with one unit sold every fifteen seconds.
Looking ahead
As Oriflame moves into its next phase in India, the brand plans to expand its skincare and wellness offerings, further strengthen its scientific capabilities and deepen its reach across Tier 2 and Tier 3 cities. With a significant share of its portfolio produced locally, India remains a strategic and forward-looking market as Oriflame continues to invest in innovation driven by skin biology and long-term health.
